Communications Director, Connecticut Hospital Association
110 Barnes Road, Wallingford, CT
rall@chime.org, 203-265-7611
Modern Healthcare – Tuesday, November 25, 2025
By Hayley DeSilva
Medicare claims tied to artificial intelligence have increased dramatically in the past seven years and the healthcare industry needs to plan for the continued growth of AI-associated care, according to a report from consulting firm Manatt Health.
AI-enabled care increased by 4,000% between 2018 and 2023, according to Manatt, based on the most recent data from the Centers for Medicare and Medicaid Services. In raw numbers, the number of Medicare beneficiaries that received AI-enabled care was 2,582 in 2018. By 2023, that number had swelled to 104,769 beneficiaries. There was little difference in the use of AI-enabled care between Medicare fee-for-service and Medicare Advantage members, the study found.
The 2023 results, though skewed by a Mayo Clinic electrocardiogram clinical trial that took place that fall, point to a significant jump in the number of AI-related claims. The increase largely was due to changes in current procedural technology codes starting in 2018, more AI medical devices receiving FDA approval, and changes to reimbursement rates, according to the study’s authors.
Outside of Minnesota, where claims jumped because of the Mayo Clinic clinical trial, the top states for utilization of AI-enabled care in 2023 were Wisconsin, Arizona, South Dakota, Iowa and Oklahoma. AI-enabled care of coronary artery disease, which was the first batch of codes approved by the American Medical Association in June 2018, was the most frequent treatment.
Manatt encouraged providers to widely adopt AI technologies to benefit patients and employees and recommended payers consider how to best incentivize the use of AI.
